SEHK:1928
SEHK:1928Hospitality

Assessing Sands China (SEHK:1928) Valuation After NBA China Games 2026 Promoter Role

Sands China (SEHK:1928) is back in focus after being confirmed as the Official Promoter for the NBA China Games 2026 at The Venetian Arena in Macao, featuring the Dallas Mavericks and Houston Rockets. See our latest analysis for Sands China. Alongside the NBA China Games announcement and the renewal of its shared services agreement with Las Vegas Sands Corp. through 2028, Sands China’s recent share price performance has been mixed. A 1-day share price return of 0.96% contrasts with a 30-day...
SEHK:512
SEHK:512Pharmaceuticals

The Bull Case For Grand Pharmaceutical Group (SEHK:512) Could Change Following Neffy Nasal Adrenaline Approval In China

Grand Pharmaceutical Group has announced that Neffy®, the world’s first adrenaline nasal spray, has obtained drug registration approval from China’s National Medical Products Administration for emergency treatment of type I allergic reactions in adults and children over 30kg, with exclusive commercialization rights in Mainland China and planned localized production within 24 months. This marks the first non-injectable adrenaline treatment approved in China, potentially broadening real-world...
SEHK:1913
SEHK:1913Luxury

A Look At Prada’s (SEHK:1913) Valuation After Its Recent Weak Share Price Performance

What Prada’s recent share performance tells you Prada (SEHK:1913) has drawn attention after a period of weaker share performance, with the stock down over the past month, past 3 months and year. This has prompted investors to reassess expectations around its current valuation. See our latest analysis for Prada. At a share price of HK$43.30, Prada’s weaker recent share price returns, including a 90 day share price return decline of 7.32%, sit alongside a 1 year total shareholder return decline...